Clinical trial
Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers
NCT02660853 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers
- Lead sponsor
- Imperial College London
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- June 30, 2017
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.